Catalog excerpts
Access More Patients. Customize Each Seal. Ovation iX™ Abdominal Stent Graft System
Open the catalog to page 1The Least Invasive Path Towards Proven Patency ULTRA LOW PROFILE TO EASE ADVANCEMENT The flexible, ultra-low 12F ID Ovation iX™ delivery system enables you to navigate through tortuous and narrow anatomies, access small vessels, and deliver a stent graft to the widest on-label range of anatomies with ease and less vessel trauma. Clinically proven occlusion rate at 1 year.1 Staged deployment of suprarenal stent allows easier, precise placement CustomSeal™ The right profile for narrow access Low profile, kink-resistant catheter built for maneuverability and flexibility DEMONSTRATED PATENCY...
Open the catalog to page 2Conformability Without Compromise Stable PROVIDE A CUSTOMSEAL™ FOR EACH PATIENT Create a customized seal that conforms to vessel wall irregularities through the CustomSeal™ polymer technology. neck diameter at 4 years PROTECT THE NECK The O-ring design provides a watertight, circumferential seal at the midpoint of the sealing ring, 13 mm below the inferior renal artery. It exerts no chronic outward force and insulates the neck from blood pressure, which results in stable neck diameter.3 OVATION SYSTEM Polymer is injected in a low-viscosity liquid state, allowing sealing ring to conform to...
Open the catalog to page 3Ovation iX Offers Simplified Delivery and Precise Placement CROSSOVER LUMEN FOR OVATION IX — THE SOLUTION TO GATE CANNULATION The crossover lumen provides an alternative to retrograde cannulation. Designed for predictable procedure times, increased efficiencies, and reduced ancillary device usage, the crossover lumen simplifies the delivery of Ovation iX™. SIMPLE, STAGED DEPLOYMENT PROMOTES PRECISE PLACEMENT With a simple, staged deployment and eight radiopaque markers, the Ovation iX system is designed to deliver precise placement and accurate deployment. CROSS-SECTION VIEW: 0.018” wire...
Open the catalog to page 4ACCESS MORE PATIENTS, CUSTOMIZE EACH SEAL In the Ovation Pivotal trial, approximately 40% of patients (66/161) treated had access vessels <6 mm in diameter, aortic neck length <10 mm, or both. Patients within this anatomically challenging group had a 0% MAE rate at 0 to 30 days and a 3.0% MAE rate at 31 to 365 days.1 13 Patients Neck length <10mm Minimum access vessel <6mm Both criteria NOTES: 1. Ovation® pivotal trial reintervention rate due to Ovation limb occlusions, N=159. Data as of July 25, 2014. 2. Makaroun, et al. JVS 2011: Sept 601-08. One year outcomes of the United States...
Open the catalog to page 5All Endologix catalogs and technical brochures
-
Ovation
26 Pages
-
AFX® Endovascular AAA System
16 Pages
-
IntuiTrak Powerlink System
4 Pages
-
AFX
6 Pages
Archived catalogs
-
IntuiTrak
4 Pages